ERCC6 and familial pancreatic carcinoma: Considering this high VAF, rs2228528 in ERCC6 is a good candidate for a biomarker to predict FOLFIRINOX responses, and is expected to be an especially useful biomarker among Asian pancreatic cancer patients with low BRCA mutation frequency.